A. Lehmer
Impact in
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
-
- Protease and Inhibitor Mechanisms
Papers in
-
- Lipid Membrane Structure and Behavior 2
-
- Protease and Inhibitor Mechanisms 4
- Co-authors
- R. Härtung (15 shared papers)Rainer Hofmann (5 shared papers)Kurt Ulm (2 shared papers)Christian Höfer (3 shared papers)Jürgen Breul (3 shared papers)Uwe Treiber (3 shared papers)Stefan Wagenpfeil (3 shared papers)H. Van Randenborgh (3 shared papers)
- Journals
- The Journal of Urology (4 papers)Cancer (2 papers)Artificial Intelligence in Medicine (1 paper)The Prostate (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- GermanyUnited States
In The Last Decade
A. Lehmer
23 papers receiving 294 citations
Peers
Comparison fields: 5 of 69
- Pharmaceutical Science 47
- Cancer Research 100
- Hematology 52
- Immunology and Allergy 21
- Urology 18
Countries citing papers authored by A. Lehmer
This map shows the geographic impact of A. Lehmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lehmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lehmer more than expected).
Fields of papers citing papers by A. Lehmer
This network shows the impact of papers produced by A. Lehmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lehmer. The network helps show where A. Lehmer may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Lehmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 75 | |
| 2 | 2000 | 36 | |
| 3 | 2004 | 34 | |
| 4 | 1996 | 30 | |
| 5 | 2004 | 29 | |
| 6 | 2005 | 17 | |
| 7 | Formulation of interleukin-2 and interferon-alpha containing ultradeformable carriers for potential transdermal application. | 1999 | 15 |
| 8 | 1995 | 11 | |
| 9 | 2003 | 11 | |
| 10 | 2006 | 8 | |
| 11 | 1985 | 6 | |
| 12 | 1985 | 6 | |
| 13 | 1986 | 6 | |
| 14 | 1996 | 5 | |
| 15 | 1984 | 4 | |
| 16 | 1992 | 3 | |
| 17 | 1991 | 3 | |
| 18 | 2004 | 2 | |
| 19 | 2004 | 2 | |
| 20 | 2004 | 1 |
About A. Lehmer
A. Lehmer is a scholar working on Molecular Biology, Cancer Research, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 307 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (4 papers), Protease and Inhibitor Mechanisms (4 papers), Nerve injury and regeneration (3 papers), Advancements in Transdermal Drug Delivery (3 papers), Sexual function and dysfunction studies (3 papers), Peptidase Inhibition and Analysis (2 papers), Dermatology and Skin Diseases (2 papers) and Lipid Membrane Structure and Behavior (2 papers). The work is most often cited by research in Pharmaceutical Science (47 citations), Cancer Research (100 citations), Hematology (52 citations), Immunology and Allergy (21 citations) and Urology (18 citations). A. Lehmer has collaborated with scholars based in Germany and United States. Frequent co-authors include R. Härtung, Rainer Hofmann, Kurt Ulm, Christian Höfer, Jürgen Breul, Uwe Treiber, Stefan Wagenpfeil, H. Van Randenborgh, Hubert Kübler and Bernd Gänsbacher. Their work appears in journals such as The Journal of Urology, Cancer, Artificial Intelligence in Medicine, The Prostate and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.